Directory
>
Manos Perros
Manos Perros
Independent Director | Venatorx Pharmaceuticals, Inc.
Lexington, Massachusetts, United States
Manos Perros
Summary
Manos Perros is a seasoned biotech and pharmaceutical executive with extensive leadership experience in the industry. Currently serving as the Executive Chairman of Venatorx Pharmaceuticals and Chairman of the Advisory Board at Aurobac Therapeutics, he has held several high-profile roles including President and CEO at Hillstar Bio and Executive Chairman at Oncxerna Therapeutics. With a strong academic background, including a postdoctoral training at Yale University, he specializes in protein biophysics and molecular virology. His career spans over two decades at renowned companies like Pfizer and AstraZeneca, where he contributed to significant advancements in antiviral therapies. Manos is known for his strategic vision and ability to drive innovation in the biotech sector, making him a valuable asset in any organization. He is passionate about developing cutting-edge therapies that address unmet medical needs.
Manos Perros
Work Experience
Independent Director at
Riva Therapeutics
October 2024 - Present
Chair of the Scientific Advisory Board at
Global Health Drug Discovery Institute
October 2024 - Present
Executive Chairman of the Board at
Venatorx Pharmaceuticals, Inc.
May 2024 - Present
Chairman of the Advisory Board at
AUROBAC THERAPEUTICS
May 2023 - Present
Pharma and Biotech Executive at
Freelance
July 2022 - Present
President and Chief Executive Officer at
Hillstar Bio
September 2023 - March 2024
Executive Chairman at
Oncxerna Therapeutics, Inc.
September 2022 - July 2023
President and Chief Executive Officer at
Entasis Therapeutics
May 2015 - July 2022
Head of Infection and Site Head, Boston R&D at
AstraZeneca
November 2010 - May 2015
Director at
Novartis
March 2010 - November 2010
Vice President & Chief Scientific Officer, Antivirals at
Pfizer, Inc.
March 2007 - March 2010
Senior Director, Urology, Gynecology and Pain Biology at
Pfizer, Inc.
September 2005 - February 2007
Senior Director, Head of Obesity Biology (interim) at
Pfizer, Inc.
November 2004 - August 2005
senior director at
Pfizer, Inc.
January 2001 - January 2005
Senior Director, Head of Infectious Diseases Biology at
Pfizer, Inc.
January 2001 - January 2005
Discovery Scientist, Antivirals at
Pfizer, Inc.
January 1996 - January 2001
Manos Perros
Education
Yale University, Postdoctoral Training
January 1994 - January 1996
pasteur institute , Phd
January 1989 - January 1994
Université libre de Bruxelles, License
January 1985 - January 1989
Frequently Asked Questions about Manos Perros
What company does Manos Perros work for?
Manos Perros is a Independent Director at Venatorx Pharmaceuticals, Inc., a company specializing in Biological products, except diagnostic.
Where Manos Perros graduated from?
Manos Perros holds a degree in Protein Biophysics, Steitz Lab from Yale University.
Is Manos Perros an immigrant?
Yes, Manos Perros is an immigrant and currently based in United States
Who is Manos Perros?
Manos Perros is a seasoned biotech and pharmaceutical executive with extensive leadership experience in the industry. Currently serving as the Executive Chairman of Venatorx Pharmaceuticals and Chairman of the Advisory Board at Aurobac Therapeutics, he has held several high-profile roles including President and CEO at Hillstar Bio and Executive Chairman at Oncxerna Therapeutics. With a strong academic background, including a postdoctoral training at Yale University, he specializes in protein biophysics and molecular virology. His career spans over two decades at renowned companies like Pfizer and AstraZeneca, where he contributed to significant advancements in antiviral therapies. Manos is known for his strategic vision and ability to drive innovation in the biotech sector, making him a valuable asset in any organization. He is passionate about developing cutting-edge therapies that address unmet medical needs.
Manos`s contact details
Colleagues
Chief Medical Officer
Vice President, Microbiology
Executive Director, Research
Vice President, Non-Clinical Safety
Vice President, Chemistry
Non Executive Director
Sr. Vice President, Biology and Grants Development
Senior Vice President, Strategic Planning and Operations
Chief Development Officer and VP of Business Development
Chief Financial Officer